Ignite Creation Date:
2025-12-24 @ 11:21 PM
Ignite Modification Date:
2025-12-25 @ 9:04 PM
Study NCT ID:
NCT00804856
Status:
COMPLETED
Last Update Posted:
2023-10-03
First Post:
2008-09-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2012-03-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-23
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-18
First Submit QC Date:
None
Study First Post Date:
2008-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-04-06
Results First Submit QC Date:
None
Results First Post Date:
2023-10-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-02
Last Update Post Date:
2023-10-03
Last Update Post Date Type:
ACTUAL